Chapter 1: Executive Summary

• Market Overview and Scope

• Key Findings and Highlights

• Summary of Market Segmentation

• Summary of Regional Landscape

• Competitive Snapshot

• Analyst Recommendations

Chapter 2: Market Introduction and Research Scope

• Market Definition and Scope

• Overview of Herpes Zoster (Shingles) and Its Clinical Burden

• Role of Vaccination in Shingles Prevention and Post-Herpetic Neuralgia Reduction

• Inclusions and Exclusions

• Research Assumptions

• Stakeholders and Beneficiaries

Chapter 3: Research Methodology

• Research Design and Approach

• Primary Research Process

• Secondary Research Sources

• Data Triangulation and Validation

• Market Estimation Techniques

• Market Forecast Approach

Chapter 4: Market Dynamics

• Market Drivers

  • Rising Global Geriatric Population Susceptible to Herpes Zoster Reactivation

  • Growing Awareness of Shingles Complications Including Post-Herpetic Neuralgia

  • Superior Efficacy and Broader Applicability of Recombinant Zoster Vaccines

  • Expansion of National Immunization Programs and Government Vaccination Guidelines

  • Increasing Prevalence of Immunocompromising Conditions Elevating Shingles Risk

  • Rising Public and Physician Awareness Campaigns on Adult Vaccination

• Market Restraints

  • High Cost of Recombinant Vaccines Limiting Access in Low-Income Regions

  • Vaccine Supply Constraints and Distribution Challenges

  • Vaccine Hesitancy and Limited Awareness in Certain Populations

• Market Opportunities

  • Expansion of Vaccination Coverage in Emerging and Underpenetrated Markets

  • Development of Next-Generation Vaccines With Improved Dosing Convenience

  • Growth of Pharmacy-Based and Retail Vaccination Programs

  • Strategic Partnerships Between Manufacturers and Public Health Agencies

• Market Challenges

  • Ensuring Consistent Global Supply Chain and Manufacturing Capacity

  • Addressing Two-Dose Regimen Compliance and Completion Rates

  • Navigating Diverse Reimbursement and Immunization Policies Across Countries

• Impact of Macroeconomic Factors on the Shingles Vaccine Market

• Impact of Public Health Policy and Immunization Advocacy on Vaccine Uptake

Chapter 5: Market Factor Analysis

• Porter's Five Forces Analysis

  • Bargaining Power of Buyers

  • Bargaining Power of Suppliers

  • Threat of New Entrants

  • Threat of Substitutes

  • Competitive Rivalry

• Value Chain Analysis

  • Raw Material and Antigen Suppliers

  • Vaccine Manufacturers and Biotechnology Companies

  • Distributors, Pharmacies, and Immunization Centers

  • Hospitals, Clinics, and Government Health Programs

• Regulatory and Compliance Framework

  • U.S. FDA Approval Pathways for Recombinant and Live Attenuated Vaccines

  • European Medicines Agency Regulatory Requirements

  • World Health Organization Prequalification and Country-Specific Immunization Guidelines

• PESTLE Analysis

• Price Trend Analysis for Recombinant and Live Attenuated Shingles Vaccines

Chapter 6: Shingles Vaccine Market, By Vaccine Type

• Overview

• Recombinant Zoster Vaccine

  • Market Overview and Dominance Rationale

  • Superior Efficacy and Extended Protection Duration

  • Suitability for Immunocompromised and Elderly Populations

• Live Attenuated Vaccine

  • Market Overview

  • Historical Adoption and Declining Preference Due to Efficacy Limitations

Chapter 7: Shingles Vaccine Market, By Age Group

• Overview

• 50 to 59 Years

  • Market Overview and Growth Rationale

  • Early Vaccination Uptake Driven by Preventive Health Awareness

• 60 to 69 Years

  • Market Overview and Dominance Rationale

  • Highest Risk Group Driving Strong Vaccination Rates

• 70 Years and Above

  • Market Overview

  • Elevated Risk of Complications Necessitating Priority Vaccination

Chapter 8: Shingles Vaccine Market, By Distribution Channel

• Overview

• Hospital Pharmacy

  • Market Overview and Dominance Rationale

  • Integration With Clinical Vaccination Programs and Physician Recommendations

• Retail Pharmacy

  • Market Overview and Growth Rationale

  • Convenient Access Through Community and Chain Pharmacies

• Online Pharmacy

  • Market Overview

  • Growing Digital Health Platforms Supporting Vaccine Scheduling and Access

• Government and Institutional Programs

  • Market Overview

  • National Immunization Initiatives and Subsidized Vaccination Campaigns

Chapter 9: Shingles Vaccine Market, By End Use

• Overview

• Hospitals

  • Market Overview and Dominance Rationale

  • High-Volume Administration and Integration With Broader Immunization Services

• Clinics and Physician Offices

  • Market Overview and Growth Rationale

  • Routine Preventive Care Visits Supporting Vaccine Uptake

• Vaccination and Public Health Centers

  • Market Overview

  • Community-Based Immunization Drives and Outreach Programs

• Other End Uses

Chapter 10: Shingles Vaccine Market, By Region

• Overview

• North America

  • Market Overview and Regional Insights

  • United States

    • Strong Immunization Infrastructure and High Recombinant Vaccine Adoption

    • Presence of Leading Vaccine Manufacturers and Robust Reimbursement Framework

  • Canada

  • Rest of North America

• Europe

  • Market Overview and Growth Trajectory

  • Germany

  • United Kingdom

  • France

  • Italy

  • Spain

  • Rest of Europe

• Asia Pacific

  • Market Overview and Fastest-Growing Region Rationale

  • China

  • Japan

  • South Korea

    • Presence of Domestic Vaccine Manufacturers and Growing Immunization Coverage

  • India

  • Rest of Asia Pacific

• Latin America

  • Market Overview

  • Brazil

  • Mexico

  • Rest of Latin America

• Middle East and Africa

  • Market Overview

  • Gulf Cooperation Council Countries

  • South Africa

  • Rest of Middle East and Africa

Chapter 11: Competitive Landscape

• Market Concentration Analysis

• Competitive Positioning and Strategic Overview

• Market Share Analysis of Key Players

• Recent Developments and Strategic Moves

  • Product Launches and Regulatory Approvals

  • Mergers, Acquisitions, and Licensing Agreements

  • Manufacturing Capacity Expansions and Supply Agreements

• Competitive Heat Map

• Key Player Benchmarking Table

Chapter 12: Company Profiles

The final report includes a complete list of companies

• GlaxoSmithKline plc

  • Company Overview

  • Financial Performance

  • Product Portfolio

  • Strategic Initiatives

  • SWOT Analysis

• Pfizer Inc.

• Merck & Co., Inc.

• CanSino Biologics Inc. (CanSinoBIO)

• Vaccitech plc

• Green Cross Corporation

• GeneOne Life Science, Inc.

• SK Bioscience Co., Ltd.

• Curevo Inc.

• Changchun BCHT Biotechnology Co., Ltd.

• Jiangsu Recbio Technology Co., Ltd.

• SK Chemicals Co., Ltd.

• Cipla Inc.

• Sanofi Pasteur

Chapter 13: Appendix

• Research Methodology Detail

• List of Abbreviations

• List of Tables and Figures

• Related Market Reports

Chapter 14: Disclaimer